A double-blind trial of adjunctive azithromycin in individuals with schizophrenia who are seropositive for Toxoplasma gondii.
Dickerson
Faith B
FB
Stallings
Cassie R
CR
Boronow
John J
JJ
Origoni
Andrea E
AE
Yolken
Robert H
RH
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000913:Antibodies, Protozoan / Q000097:blood*; D017963:Azithromycin / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D011618:Psychotic Disorders / Q000150:complications / Q000188:drug therapy / Q000469:parasitology; D012559:Schizophrenia / Q000150:complications* / Q000188:drug therapy*; D014122:Toxoplasma / Q000276:immunology*; D014123:Toxoplasmosis / Q000150:complications*; D055815:Young Adult
D000900:Anti-Bacterial Agents; D000913:Antibodies, Protozoan; D017963:Azithromycin